subject: UNII:MQ908Y1ZB2

object_name: Chronic pain


subject: CHEBI:27732

subject_name: Caffeine

object_name: chronic pain (diagnosis)

tested_intervention: unsure


subject: CHEBI:27732


subject: CHEBI:27999

subject_name: Tolbutamide


subject: CHEBI:27999


subject: UMLS:C1698989

subject_name: tomatoes - non-drug agent

object_name: metabolic dysfunction-associated steatotic liver disease

tested_intervention: yes


subject: UMLS:C1698989

object_name: superficial epidermolytic ichthyosis


subject: UMLS:C1698989

object_name: irritable bowel syndrome


subject: PUBCHEM.COMPOUND:60858

object_name: sleep disorder, initiating and maintaining sleep


subject: PUBCHEM.COMPOUND:60858

object_name: insomnia


subject: UNII:EW71EE171J

subject_name: Volinanserin


subject: UNII:EW71EE171J


subject: UMLS:C0212182


subject: UMLS:C0212182


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:141441

subject_name: Ile-Thr


subject: CHEBI:141441

object_name: childhood acute myeloid leukemia


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Arrhythmia


subject: CHEBI:6801

subject_name: Metformin

object_name: congestive heart failure


subject: UMLS:C4055462

subject_name: Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:18145

subject_name: Vitamin E

object_name: Drusen stage macular degeneration


subject: CHEBI:18145

object_name: Drusen (degenerative) of macula, bilateral


subject: CHEBI:18145

object_name: glycogen storage disease II


subject: CHEBI:18145

object_name: age-related macular degeneration


subject: CHEBI:18145

object_name: Reticular pseudodrusen


subject: CHEBI:18145

object_name: Soft drusen


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C3827180

subject_name: Sulforadex

object_name: prostate carcinoma


subject: UMLS:C3827180

object_name: prostate cancer


subject: UNII:7DP3NTV15T

subject_name: BLEOMYCIN SULFATE

object_name: Stage III Childhood Hodgkin Lymphoma


subject: UNII:7DP3NTV15T

object_name: Stage II Childhood Hodgkin Lymphoma


subject: UNII:7DP3NTV15T

object_name: Stage I Childhood Hodgkin Lymphoma


subject: UNII:7DP3NTV15T

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: UNII:7DP3NTV15T

object_name: Childhood Mixed Cellularity Classic Hodgkin Lymphoma


subject: UNII:7DP3NTV15T

object_name: Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma


subject: UNII:7DP3NTV15T

object_name: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma


subject: UNII:7DP3NTV15T

object_name: Childhood Nodular Sclerosis Classic Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:3139

subject_name: bleomycin


subject: CHEBI:3139


subject: CHEBI:3139


subject: CHEBI:3139


subject: CHEBI:3139


subject: CHEBI:3139


subject: CHEBI:3139


subject: CHEBI:3139


subject: CHEBI:28509

subject_name: chloroethene

object_name: pancreatic neoplasm


subject: CHEBI:28509

object_name: exocrine pancreatic carcinoma


subject: CHEBI:28509

object_name: malignant pancreatic neoplasm


subject: UMLS:C2240391

subject_name: Herbal medicine (product)


subject: UMLS:C2240391


subject: UMLS:C2240391


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan

object_name: Adult Solid Neoplasm


subject: UMLS:C4527158


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Primary bacterial peritonitis


subject: CHEBI:40279

object_name: hepatic encephalopathy


subject: CHEBI:40279

object_name: Ascites


subject: CHEBI:40279

object_name: Ascites, CTCAE


subject: CHEBI:40279

object_name: varicose veins


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: pancreatitis


subject: CHEBI:230430

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:230430

object_name: Pancreatitis, CTCAE 3.0


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: UNII:OR3S9IF86U


subject: UNII:OR3S9IF86U


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Childhood Breast Carcinoma


subject: CHEBI:85990

object_name: breast carcinoma


subject: CHEBI:85990

object_name: breast cancer


subject: UNII:D07V79Q44T


subject: UNII:D07V79Q44T


subject: UNII:D07V79Q44T


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:5558

subject_name: Guanfacine

object_name: trigeminal neuralgia


subject: CHEBI:6456

subject_name: Lidocaine


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: HIV infection


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Steroid-dependent nephrotic syndrome


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: non-small cell lung carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: CAPN5-related vitreoretinopathy


subject: CHEBI:41879

object_name: proliferative vitreoretinopathy


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: MESH:D006495


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UNII:RFO6IL3D3M

subject_name: (R)-Naltrexone methylbromide

object_name: pancreatic neoplasm


subject: UNII:RFO6IL3D3M

object_name: exocrine pancreatic carcinoma


subject: UNII:RFO6IL3D3M

object_name: malignant pancreatic neoplasm


subject: CHEBI:136007

subject_name: methylnaltrexone


subject: CHEBI:136007


subject: CHEBI:136007


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: acne


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:201491

subject_name: Amoxicillin Clavulanate

object_name: Postoperative Complications


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: DRUGBANK:DB19248

subject_name: Bifidobacterium longum


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: CHEBI:10033

subject_name: Warfarin

object_name: Acute gastrointestinal hemorrhage


subject: CHEBI:74705

subject_name: Met-Leu

object_name: chemotherapy-induced alopecia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol

object_name: glioblastoma


subject: UNII:CLH5FT6412

object_name: Brain Stem Glioblastoma


subject: UNII:CLH5FT6412

object_name: glioma susceptibility 1


subject: UNII:CLH5FT6412

object_name: Childhood Glioblastoma


subject: UNII:CLH5FT6412

object_name: adult glioblastoma


subject: UMLS:C4744839

subject_name: Pharmacological Ascorbate


subject: UMLS:C4744839


subject: UMLS:C4744839


subject: UMLS:C4744839


subject: UMLS:C4744839


subject: UMLS:C4083270

subject_name: BIBW 2992


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat

object_name: Tumor Mass


subject: PUBCHEM.COMPOUND:157010068

subject_name: Calcium citrate

object_name: vitamin D deficiency


subject: PUBCHEM.COMPOUND:157010068

object_name: acute lymphoblastic leukemia


subject: UNII:MLM29U2X85


subject: UNII:MLM29U2X85


subject: UMLS:C1144384

subject_name: G-3139 oligonucleotide

object_name: Advanced Melanoma


subject: UMLS:C1258613

subject_name: oblimersen sodium


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: EBV Infection


subject: UNII:7XL5ISS668

object_name: testicular lymphoma


subject: UNII:7XL5ISS668

object_name: intraocular lymphoma


subject: UNII:7XL5ISS668

object_name: small intestine lymphoma


subject: UNII:7XL5ISS668

object_name: MALT lymphoma


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668

object_name: B-cell small lymphocytic lymphoma stage III


subject: UNII:7XL5ISS668

object_name: Marginal zone lymphoma stage III


subject: UNII:7XL5ISS668

object_name: Mantle cell lymphoma stage III


subject: UNII:7XL5ISS668

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: B-cell small lymphocytic lymphoma stage I


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UNII:7XL5ISS668

object_name: Stage III Adult Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Adult Burkitt Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Marginal zone lymphoma recurrent


subject: UNII:7XL5ISS668

object_name: Marginal zone lymphoma stage I


subject: UNII:7XL5ISS668

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Mantle cell lymphoma recurrent


subject: UNII:7XL5ISS668

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Marginal zone lymphoma stage IV


subject: UNII:7XL5ISS668

object_name: Mantle cell lymphoma stage I


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: splenic marginal zone lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Mantle cell lymphoma stage IV


subject: UNII:7XL5ISS668

object_name: Stage II Adult Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: hepatosplenic T-cell lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage I Adult Burkitt Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage I Adult Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: noncutaneous extranodal lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage IV Adult Burkitt Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UNII:7XL5ISS668

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UNII:7XL5ISS668

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UNII:7XL5ISS668

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UNII:7XL5ISS668

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:7XL5ISS668

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: primary cutaneous B-cell lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: recurrent cutaneous T-cell lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Cutaneous T-cell lymphoma stage II


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Cutaneous T-cell lymphoma stage I


subject: UNII:7XL5ISS668

object_name: Cutaneous T-cell lymphoma stage IV


subject: UNII:7XL5ISS668

object_name: Stage I Adult Immunoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UNII:7XL5ISS668

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UNII:7XL5ISS668

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: UNII:7XL5ISS668

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: UNII:7XL5ISS668

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UNII:7XL5ISS668

object_name: T-cell large granular lymphocyte leukemia


subject: UNII:7XL5ISS668

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:7XL5ISS668

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Untreated Hairy Cell Leukemia


subject: UNII:7XL5ISS668

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:7XL5ISS668

object_name: Waldenstrom macroglobulinemia


subject: UNII:7XL5ISS668

object_name: refractory hairy cell leukemia


subject: UMLS:C1832035

object_name: EBV Infection


subject: UMLS:C1832035

object_name: testicular lymphoma


subject: UMLS:C1832035

object_name: intraocular lymphoma


subject: UMLS:C1832035

object_name: small intestine lymphoma


subject: UMLS:C1832035

object_name: MALT lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035

object_name: B-cell small lymphocytic lymphoma stage III


subject: UMLS:C1832035

object_name: Marginal zone lymphoma stage III


subject: UMLS:C1832035

object_name: Mantle cell lymphoma stage III


subject: UMLS:C1832035

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C1832035

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UMLS:C1832035

object_name: B-cell small lymphocytic lymphoma stage I


subject: UMLS:C1832035

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UMLS:C1832035

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C1832035

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UMLS:C1832035

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UMLS:C1832035

object_name: Stage III Adult Hodgkin Lymphoma


subject: UMLS:C1832035

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C1832035

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: UMLS:C1832035

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C1832035

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C1832035

object_name: Marginal zone lymphoma stage I


subject: UMLS:C1832035

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UMLS:C1832035

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C1832035

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Marginal zone lymphoma stage IV


subject: UMLS:C1832035

object_name: Mantle cell lymphoma stage I


subject: UMLS:C1832035

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UMLS:C1832035

object_name: splenic marginal zone lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UMLS:C1832035

object_name: Mantle cell lymphoma stage IV


subject: UMLS:C1832035

object_name: Stage II Adult Hodgkin Lymphoma


subject: UMLS:C1832035

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C1832035

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: UMLS:C1832035

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C1832035

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage I Adult Burkitt Lymphoma


subject: UMLS:C1832035

object_name: Stage I Adult Hodgkin Lymphoma


subject: UMLS:C1832035

object_name: noncutaneous extranodal lymphoma


subject: UMLS:C1832035

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: UMLS:C1832035

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C1832035

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UMLS:C1832035

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: UMLS:C1832035

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C1832035

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1832035

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UMLS:C1832035

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UMLS:C1832035

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1832035

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C1832035

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C1832035

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UMLS:C1832035

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UMLS:C1832035

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1832035

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UMLS:C1832035

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1832035

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C1832035

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1832035

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UMLS:C1832035

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C1832035

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C1832035

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: UMLS:C1832035

object_name: Cutaneous T-cell lymphoma stage II


subject: UMLS:C1832035

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: UMLS:C1832035

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C1832035

object_name: Cutaneous T-cell lymphoma stage I


subject: UMLS:C1832035

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C1832035

object_name: Stage I Adult Immunoblastic Lymphoma


subject: UMLS:C1832035

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UMLS:C1832035

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C1832035

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: UMLS:C1832035

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: UMLS:C1832035

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UMLS:C1832035

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C1832035

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C1832035

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Untreated Hairy Cell Leukemia


subject: UMLS:C1832035

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1832035

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C1832035

object_name: refractory hairy cell leukemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: testicular lymphoma


subject: UNII:4F4X42SYQ6

object_name: intraocular lymphoma


subject: UNII:4F4X42SYQ6

object_name: small intestine lymphoma


subject: UNII:4F4X42SYQ6

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage III Adult Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage III Adult Burkitt Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage II Adult Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: hepatosplenic T-cell lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage I Adult Burkitt Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage I Adult Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6

object_name: noncutaneous extranodal lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage IV Adult Burkitt Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:4F4X42SYQ6

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: anaplastic large cell lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:4F4X42SYQ6

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UNII:4F4X42SYQ6

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: primary cutaneous B-cell lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6

object_name: recurrent cutaneous T-cell lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Cutaneous T-cell lymphoma stage II


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Cutaneous T-cell lymphoma stage I


subject: UNII:4F4X42SYQ6

object_name: Cutaneous T-cell lymphoma stage IV


subject: UNII:4F4X42SYQ6

object_name: Stage I Adult Immunoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UNII:4F4X42SYQ6

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: UNII:4F4X42SYQ6

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: UNII:4F4X42SYQ6

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UNII:4F4X42SYQ6

object_name: T-cell large granular lymphocyte leukemia


subject: UNII:4F4X42SYQ6

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:4F4X42SYQ6

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:4F4X42SYQ6

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:4F4X42SYQ6

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:4F4X42SYQ6

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:4F4X42SYQ6

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:4F4X42SYQ6

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:4F4X42SYQ6

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:4F4X42SYQ6

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

subject_name: rituximab

object_name: testicular lymphoma


subject: UMLS:C0295415

object_name: intraocular lymphoma


subject: UMLS:C0295415

object_name: small intestine lymphoma


subject: UMLS:C0295415

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C0295415

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: Stage III Adult Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C0295415

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: UMLS:C0295415

object_name: Stage II Adult Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C0295415

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage I Adult Burkitt Lymphoma


subject: UMLS:C0295415

object_name: Stage I Adult Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: noncutaneous extranodal lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: UMLS:C0295415

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C0295415

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C0295415

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C0295415

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C0295415

object_name: anaplastic large cell lymphoma


subject: UMLS:C0295415

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C0295415

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0295415

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C0295415

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0295415

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UMLS:C0295415

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0295415

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UMLS:C0295415

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C0295415

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: UMLS:C0295415

object_name: Cutaneous T-cell lymphoma stage II


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C0295415

object_name: Cutaneous T-cell lymphoma stage I


subject: UMLS:C0295415

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C0295415

object_name: Stage I Adult Immunoblastic Lymphoma


subject: UMLS:C0295415

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UMLS:C0295415

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C0295415

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: UMLS:C0295415

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: UMLS:C0295415

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UMLS:C0295415

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C0295415

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C0295415

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0295415

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0061184

subject_name: GEL protein, Gelonium multiflorum

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0061184

object_name: acute myeloid leukemia


subject: UMLS:C0061184

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C0061184

object_name: chronic myelomonocytic leukemia


subject: UMLS:C0061184

object_name: myelodysplastic syndrome with excess blasts


subject: UMLS:C0061184

object_name: myeloproliferative neoplasm


subject: CHEBI:52763

object_name: hypogonadotropic hypogonadism


subject: UMLS:C4733271

subject_name: SB injection

object_name: colorectal cancer


subject: UMLS:C4733271

object_name: colorectal carcinoma


subject: UMLS:C4733271

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Childhood Breast Carcinoma


subject: CHEBI:60789

object_name: breast carcinoma


subject: CHEBI:60789

object_name: breast cancer


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:231614

subject_name: Nivolumab

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C2346820


subject: DRUGBANK:DB09106

subject_name: hetastarch

object_name: subarachnoid hemorrhage


subject: MESH:D000077325

subject_name: Ringer's Lactate


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Chemotherapeutic Agent Toxicity


subject: UNII:PVI5M0M1GW

object_name: unspecified adult solid tumor, protocol specific


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:50730

subject_name: Montelukast

object_name: neonatal sepsis


subject: CHEBI:50730

object_name: Bacterial sepsis of newborn


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Postoperative Hemorrhage


subject: CHEBI:63610

object_name: Intraoperative Hemorrhage


subject: CHEBI:7625

subject_name: nordihydroguaiaretic acid

object_name: prostate carcinoma


subject: CHEBI:7625

object_name: prostate cancer


subject: CHEBI:73468

subject_name: Masoprocol


subject: CHEBI:73468


subject: CHEBI:131164

subject_name: Osugacestat

object_name: cancer


subject: CHEBI:131164

object_name: neoplasm


subject: GTOPDB:13624

subject_name: inclisiran

object_name: Familial hypercholesterolemia - heterozygous


subject: PUBCHEM.COMPOUND:17753757

subject_name: Pimecrolimus

object_name: atopic eczema


subject: CHEBI:31623

subject_name: Fluocinolone acetonide

object_name: retinal vein occlusion


subject: CHEBI:31623

object_name: Macular Edema


subject: UMLS:C3497689

subject_name: Arctium lappa whole extract

object_name: acne


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Addiction


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: sclerosing cholangitis


subject: CHEBI:5001

object_name: primary sclerosing cholangitis


subject: CHEBI:36796

subject_name: duloxetine

object_name: amphetamine abuse


subject: CHEBI:36796

object_name: substance-related disorder


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: Expulsion of implant


subject: PUBCHEM.COMPOUND:3467

object_name: Complication of implant


subject: PUBCHEM.COMPOUND:3467

object_name: antibiotic side-effect


subject: PUBCHEM.COMPOUND:3467

object_name: Infection and inflammatory reaction due to internal orthopedic fixation device


subject: PUBCHEM.COMPOUND:3467

object_name: Implant site infection


subject: PUBCHEM.COMPOUND:3467

object_name: Implant Capsular Contracture


subject: PUBCHEM.COMPOUND:3467

object_name: Implant site pocket infection


subject: CHEBI:474053

subject_name: Cefazolin


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: UMLS:C3272413

subject_name: STAT3 Inhibitor OPB-51602

object_name: Malignant Solid Neoplasm


subject: UNII:37NT056AT4

subject_name: Remetinostat

object_name: squamous cell carcinoma


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Restless legs


subject: CHEBI:38290

object_name: chronic kidney disease


subject: CHEBI:38290

object_name: Chronic uremia


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: MESH:C107375

subject_name: vitamin CE


subject: MESH:C107375


subject: MESH:C107375


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:3766

subject_name: Clozapine

object_name: cannabis abuse


subject: CHEBI:3766

object_name: Mentally ill chemical abuse


subject: CHEBI:3766

object_name: Dual diagnosis (psychiatry)


subject: CHEBI:32682

subject_name: L-argininium

object_name: schizophrenia


subject: CHEBI:32682

object_name: schizoaffective disorder


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:15372


subject: CHEBI:15372


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: CHEBI:2469

subject_name: Adefovir

object_name: glioblastoma


subject: CHEBI:2469

object_name: Childhood Glioblastoma


subject: CHEBI:2469

object_name: adult glioblastoma


subject: CHEBI:2469

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:2469

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:2469

object_name: anaplastic astrocytoma


subject: UMLS:C5575704

subject_name: Gene Therapy [APC]


subject: UMLS:C5575704


subject: UMLS:C5575704


subject: UMLS:C5575704


subject: UMLS:C5575704


subject: UMLS:C5575704


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: heart valve disorder


subject: CHEBI:6904

subject_name: Metoprolol


subject: UMLS:C0795657

subject_name: Aralast

object_name: graft versus host disease


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: Tinnitus


subject: CHEBI:7640

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:7640

object_name: Tinnitus, CTCAE 3.0


subject: CHEBI:7640

object_name: Tinnitus, Subjective


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:63631


subject: CHEBI:63631


subject: CHEBI:63631


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:5523

subject_name: Goserelin

object_name: Stage II Prostate Cancer AJCC v6


subject: CHEBI:5523

object_name: Stage II Prostate Cancer AJCC v8


subject: CHEBI:5523

object_name: Carcinoma of the prostate stage II


subject: CHEBI:5523

object_name: Stage II Prostate Cancer AJCC v7


subject: CHEBI:5523

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:5523

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:5523

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:5523

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:5523

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:5523

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:5523

object_name: Carcinoma of the prostate stage III


subject: CHEBI:5523

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: PUBCHEM.COMPOUND:21879648


subject: UNII:3JB65R8TZZ

subject_name: INSULIN 338

object_name: type 2 diabetes mellitus


subject: UNII:3JB65R8TZZ

object_name: Diabetes


subject: UNII:3JB65R8TZZ

object_name: diabetes mellitus


subject: UNII:3JB65R8TZZ

object_name: type 1 diabetes mellitus 1


subject: UNII:3JB65R8TZZ

object_name: type 1 diabetes mellitus


subject: UMLS:C1541160

subject_name: volociximab

object_name: melanoma


subject: UMLS:C1541160

object_name: Embolism, Tumor


subject: UMLS:C1541160

object_name: Neoplasm Metastasis


subject: UMLS:C1541160

object_name: Metastatic Lesion


subject: GTOPDB:10236


subject: GTOPDB:10236


subject: GTOPDB:10236


subject: GTOPDB:10236


subject: CHEMBL.COMPOUND:CHEMBL2108061

subject_name: VOLOCIXIMAB


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4305


subject: CHEBI:4305


subject: PUBCHEM.COMPOUND:145954559

object_name: glioma


subject: PUBCHEM.COMPOUND:145954559

object_name: malignant glioma


subject: UMLS:C4053635

subject_name: IDH1(R132) Inhibitor IDH305


subject: UMLS:C4053635


subject: PUBCHEM.COMPOUND:152165

object_name: Tingling


subject: PUBCHEM.COMPOUND:152165

object_name: Paresthesia, CTCAE


subject: PUBCHEM.COMPOUND:152165

object_name: Paresthesia


subject: PUBCHEM.COMPOUND:152165

object_name: Chest pain


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:58097

object_name: Post-Dural Puncture Headaches


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C4733228

subject_name: Oshadi D

object_name: non-small cell lung carcinoma


subject: UMLS:C4733229

subject_name: Oshadi R


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IIA Cervical Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: cervical adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: cervical adenosquamous carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Cervical Squamous Cell Carcinoma, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:233291

subject_name: Saredutant

object_name: generalized anxiety


subject: CHEBI:233291

object_name: generalized anxiety disorder


subject: CHEBI:27374

subject_name: Levoinositol

object_name: testosterone measurement


subject: CHEBI:27372


subject: CHEBI:37845

subject_name: growth hormone

object_name: hereditary endocrine growth disease


subject: CHEBI:37845

object_name: Delayed puberty


subject: CHEBI:37845

object_name: malnutrition


subject: CHEBI:169956

subject_name: Gly-His


subject: CHEBI:169956


subject: CHEBI:169956


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UniProtKB:P12824

subject_name: GH_HCMVA Envelope glycoprotein H (sprot)


subject: UniProtKB:P12824


subject: UniProtKB:P12824


subject: PR:000007957

subject_name: gamma-glutamyl hydrolase


subject: PR:000007957


subject: PR:000007957


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: PR:000007968


subject: UMLS:C1328652

subject_name: KOS 862

object_name: lung cancer


subject: UMLS:C1328652

object_name: lung neoplasm


subject: UMLS:C1328652

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:4622926

subject_name: Epothilone D


subject: PUBCHEM.COMPOUND:4622926


subject: PUBCHEM.COMPOUND:4622926


subject: UMLS:C2830125

object_name: Plexosarcoma


subject: UMLS:C2830125

object_name: Childhood Gastrointestinal Stromal Tumor


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:145371


subject: CHEBI:145373

subject_name: Pexidartinib


subject: CHEBI:145373


subject: CHEBI:8988

object_name: pancreatic ductal adenocarcinoma


subject: MESH:C079198

subject_name: S 1 (combination)


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: heart failure


subject: PUBCHEM.COMPOUND:24993045

object_name: Heart Failure, CTCAE


subject: UNII:7UP768IP4M

object_name: Lumbar radiculopathy


subject: CHEBI:202717

object_name: Helicobacter pylori infection


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Peyronie disease


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:77733

subject_name: Verapamil


subject: UMLS:C0030956

subject_name: Peptides

object_name: glioblastoma


subject: UMLS:C0030956

object_name: Childhood Glioblastoma


subject: UMLS:C0030956

object_name: adult glioblastoma


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: GTOPDB:12962

subject_name: sotatercept

object_name: pulmonary hypertension, primary, 1


subject: GTOPDB:12962

object_name: pulmonary hypertension


subject: GTOPDB:12962

object_name: idiopathic pulmonary arterial hypertension


subject: GTOPDB:12962

object_name: pulmonary arterial hypertension


subject: CHEMBL.COMPOUND:CHEMBL1743073

subject_name: SOTATERCEPT


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UNII:5OGS5K699E

subject_name: Merestinib

object_name: biliary tract cancer


subject: UNII:5OGS5K699E

object_name: Disseminated Malignant Neoplasm


subject: UNII:5OGS5K699E

object_name: Embolism, Tumor


subject: UNII:5OGS5K699E

object_name: Neoplasm Metastasis


subject: UNII:5OGS5K699E

object_name: Advanced cancer


subject: UNII:5OGS5K699E

object_name: liver carcinoma


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: Cryoglobulinemic vasculitis


subject: UNII:R30772KCU0

object_name: monoclonal gammopathy of uncertain significance


subject: UMLS:C4079755

object_name: type 2 diabetes mellitus


subject: UNII:97RWB5S1U6

subject_name: Idarucizumab

object_name: Hemorrhage


subject: CHEBI:36047

subject_name: antibacterial drug

object_name: neoplasm


subject: UMLS:C0003308

subject_name: Antifungal Agents


subject: CHEBI:35820

subject_name: antiprotozoal drug


subject: UMLS:C0003416

subject_name: Antiprotozoal Agents


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: biliary tract disorder


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:80961


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: Myelodysplasia


subject: UMLS:C2347619


subject: CHEBI:174615

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:174615

object_name: Recurrent High Risk Myelodysplastic Syndrome


subject: CHEBI:174615

object_name: Plasma cell myeloma recurrent


subject: CHEBI:174615

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:174615

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:174615

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:174615

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:174615

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:174615

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:174615

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:174615

object_name: High Risk Acute Myeloid Leukemia


subject: CHEBI:174615

object_name: lymphoproliferative syndrome


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:168396


subject: CHEBI:168396

object_name: Recurrent High Risk Myelodysplastic Syndrome


subject: CHEBI:168396

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:168396

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:168396


subject: CHEBI:168396

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570

object_name: Plasma cell myeloma recurrent


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:9570

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:9570

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:9570

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:9570

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:9570

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:9570

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:9570

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:9570

object_name: High Risk Acute Myeloid Leukemia


subject: CHEBI:9570

object_name: lymphoproliferative syndrome


subject: PUBCHEM.COMPOUND:56842157

subject_name: CHOP regimen

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:56842157

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: GTOPDB:12347

subject_name: penpulimab

object_name: metastatic pheochromocytoma


subject: GTOPDB:12347

object_name: malignant adrenal gland pheochromocytoma


subject: GTOPDB:12347

object_name: Malignant Paraganglioma


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: PUBCHEM.COMPOUND:56674991

subject_name: Brincidofovir

object_name: smallpox


subject: UMLS:C1723519

object_name: Alzheimer disease


subject: CHEBI:253342

subject_name: Alosetron

object_name: irritable bowel syndrome


subject: CHEBI:44915

subject_name: Propofol

object_name: Postoperative cognitive dysfunction


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C2934225


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Severe Aplastic Anemia


subject: UMLS:C0003442

object_name: severe aplastic anemia


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Radiographic contrast agent nephropathy


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:154623230

subject_name: Deucrictibant

object_name: hereditary angioedema


subject: PUBCHEM.COMPOUND:154623230

object_name: Hereditary angioedema attack


subject: PUBCHEM.COMPOUND:154623230

object_name: hereditary angioedema type 2


subject: PUBCHEM.COMPOUND:154623230

object_name: hereditary angioedema with normal C1Inh


subject: PUBCHEM.COMPOUND:154623230

object_name: hereditary angioedema type 1


subject: PUBCHEM.COMPOUND:154623230

object_name: hereditary angioedema with C1Inh deficiency


subject: PUBCHEM.COMPOUND:154623230

object_name: hereditary angioedema type 3


subject: PUBCHEM.COMPOUND:154623230

object_name: Hereditary Angioedema Types I and II


subject: PUBCHEM.COMPOUND:154623230

object_name: C1 esterase inhibitor [C1-INH] deficiency


subject: PUBCHEM.COMPOUND:154623230

object_name: C1 inhibitor deficiency


subject: UNII:69GCA2KX22

subject_name: DEUCRICTIBANT


subject: UNII:69GCA2KX22


subject: UNII:69GCA2KX22


subject: UNII:69GCA2KX22


subject: UNII:69GCA2KX22


subject: UNII:69GCA2KX22


subject: UNII:69GCA2KX22


subject: UNII:69GCA2KX22


subject: UNII:69GCA2KX22


subject: UNII:69GCA2KX22


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: Nelson syndrome


subject: UMLS:C4085973

object_name: breast neoplasm


subject: UMLS:C4085973

object_name: gastric neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: UMLS:C2983744

subject_name: Darleukin


subject: UMLS:C0718234

subject_name: Acthar

object_name: EXCESS LMW-DNA


subject: CHEBI:15765

subject_name: Levodopa

object_name: Angelman syndrome


subject: CHEMBL.COMPOUND:CHEMBL4549658


subject: UNII:EC2P9H3A8S


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: myocardial infarction


subject: CHEBI:85078

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:85078

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:85078

object_name: angina unstable


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:233364

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:233364

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:233364

object_name: Plasma cell myeloma refractory


subject: CHEBI:233364

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:233364

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:233364

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:233364

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:233364

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:233364

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:233364

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:5613

subject_name: Haloperidol

object_name: migraine


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Complications of Diabetes Mellitus


subject: UNII:U2514Q0PG1

subject_name: Lithium aspartate

object_name: Parkinson disease


subject: UMLS:C1966347

subject_name: lithium aspartate


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: skin carcinoma


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEMBL.COMPOUND:CHEMBL2108570

subject_name: ABOBOTULINUMTOXINA

object_name: Skin Wrinkling


subject: UMLS:C2729275

subject_name: INJECTION, ABOBOTULINUMTOXINA, 5 UNITS


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: diffuse large B-cell lymphoma


subject: UNII:U2I8T43Y7R

object_name: high grade B-cell lymphoma


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Malignant neoplasm of female breast


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:8988

object_name: Ewing sarcoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:78320

subject_name: Lactic acid

object_name: end stage renal failure


subject: CHEBI:78320

object_name: Chronic uremia


subject: CHEBI:92998

subject_name: Guanabenz


subject: CHEBI:92998


subject: CHEBI:8382

subject_name: Prednisone

object_name: Duchenne muscular dystrophy


subject: DRUGBANK:DB19248

subject_name: Bifidobacterium longum

object_name: Asthenia


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:3082777

object_name: HIV-1 infection


subject: CHEBI:74705

subject_name: Met-Leu

object_name: allergic asthma


subject: CHEBI:74705

object_name: perennial allergic rhinitis


subject: CHEBI:74705

object_name: Dust mite allergy


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Drug usage


subject: CHEBI:41423

subject_name: Celecoxib

object_name: carcinoma of esophagus


subject: CHEBI:41423

object_name: esophageal cancer


subject: CHEBI:41423

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:41423

object_name: neoplasm of esophagus


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Dysesthesia


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Estrogen Receptor Positive


subject: CHEBI:2704

object_name: triple-negative breast carcinoma


subject: CHEBI:2704

object_name: Estrogen Receptor Negative


subject: CHEBI:2704

object_name: Progesterone Receptor Positive


subject: CHEBI:2704

object_name: Progesterone Receptor Negative


subject: CHEBI:2704

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:2704

object_name: Carcinoma breast stage IV


subject: CHEBI:2704

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: HER2/Neu Negative


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Depression, psychotic


subject: CHEBI:8707

object_name: Severe major depression with psychotic features


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Tobacco user


subject: CHEBI:167574

object_name: Tobacco use history


subject: CHEBI:167574

object_name: Encounter due to tobacco use


subject: CHEBI:71952

subject_name: Dactolisib

object_name: acute myeloid leukemia


subject: CHEBI:71952

object_name: Chronic myelogenous leukemia with crisis of blast cells


subject: CHEBI:71952

object_name: acute lymphoblastic leukemia


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UNII:47M5ZXU844

object_name: Cachexia


subject: CHEMBL.COMPOUND:CHEMBL3545174


subject: CHEBI:18358

subject_name: Methoxsalen

object_name: graft versus host disease


subject: CHEBI:8499

subject_name: Propranolol

object_name: Burn injury


subject: UNII:35A26E427H

subject_name: Reslizumab

object_name: loiasis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: collecting duct carcinoma


subject: UNII:N4JTA67V3O

subject_name: MITAPIVAT SULFATE

object_name: Hereditary red blood cell disorder


subject: UNII:2WTV10SIKH

subject_name: Mitapivat


subject: CHEMBL.COMPOUND:CHEMBL3545093

object_name: inherited lipid metabolism disorder


subject: CHEMBL.COMPOUND:CHEMBL3545093

object_name: Dyslipidemia


subject: CHEMBL.COMPOUND:CHEMBL3545093

object_name: hypertriglyceridemia


subject: CHEMBL.COMPOUND:CHEMBL3545093

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:91899

object_name: Crohn disease


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:63589

subject_name: Etravirine

object_name: chronic hepatitis C virus infection


subject: CHEBI:184662

object_name: hepatitis B


subject: CHEBI:184662


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:63608


subject: UNII:1IAT42T80T

subject_name: Batefenterol

object_name: COPD, severe early onset


subject: UNII:1IAT42T80T

object_name: chronic obstructive pulmonary disease


subject: CHEBI:73462

subject_name: Cys-Ser

object_name: osteoarthritis, knee


subject: CHEBI:30514

subject_name: caesium atom


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole


subject: CHEBI:74814

subject_name: Ser-Gly


subject: CHEBI:33351

subject_name: seaborgium atom


subject: CHEBI:3077

subject_name: Betamethasone

object_name: interstitial lung disease


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:31859

subject_name: Modafinil

object_name: amphetamine abuse


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Pressure injury stage IV


subject: CHEBI:144903

object_name: Pressure ulcer stage 3 (disorder)


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: CHEBI:41423

subject_name: Celecoxib

object_name: hip pain chronic


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:53762


subject: CHEBI:32315

subject_name: Zopiclone


subject: CHEBI:135954

subject_name: Bilastine

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C5447409

subject_name: Simridarlimab

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5447409

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C5447409

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:31593

subject_name: fasudil hydrochloride

object_name: prostate cancer


subject: CHEBI:43871

subject_name: Fasudil


subject: UMLS:C0526099


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UNII:S4NL6N7DWD

object_name: superficial urinary bladder carcinoma


subject: UMLS:C5417860

subject_name: Interleukin-15 Agonist Fusion Protein SHR1501


subject: CHEBI:32599

object_name: Headache


subject: CHEBI:32599

object_name: Headache, CTCAE


subject: CHEBI:32599

object_name: migraine


subject: CHEBI:32599

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C5854586

subject_name: Anti-GARP/PD-L1 Bispecific Antibody BPB-101

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854586

object_name: Adult Solid Neoplasm


subject: UMLS:C5854586

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:2269

object_name: chest syndrome


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Childhood Breast Carcinoma


subject: CHEBI:144094

object_name: breast carcinoma


subject: CHEBI:144094

object_name: breast cancer


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Shock


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: interstitial lung disease


subject: UMLS:C3887574

object_name: Advanced Malignant Solid Neoplasm


subject: DRUGBANK:DB15656

subject_name: ChAdOx1 nCoV-19

object_name: Reactogenicity


subject: UMLS:C5383286


subject: DRUGBANK:DB15854


subject: DRUGBANK:DB15854


subject: CHEBI:15611

subject_name: Sarcosine

object_name: endogenous depression


subject: CHEBI:15611

object_name: major depressive disorder


subject: CHEBI:15611

object_name: Depressed mood


subject: CHEBI:15611

object_name: Cancer patients and suicide and depression


subject: CHEBI:15611

object_name: Depressed - symptom


subject: CHEBI:15611

object_name: Depression, CTCAE


subject: UMLS:C0036228

subject_name: sarcosine


subject: UMLS:C0036228


subject: UMLS:C0036228


subject: UMLS:C0036228


subject: UMLS:C0036228


subject: UMLS:C0036228


subject: CHEBI:48923

subject_name: erythromycin

object_name: Stomach cancer


subject: CHEBI:48923

object_name: gastric cancer


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: treatment-refractory schizophrenia


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: UNII:72W09924WP

subject_name: Asoprisnil

object_name: uterine fibroid


subject: UNII:72W09924WP

object_name: leiomyoma


subject: PUBCHEM.COMPOUND:13620391

subject_name: ZOLPIDEM TARTRATE

object_name: sleep disorder, initiating and maintaining sleep


subject: PUBCHEM.COMPOUND:13620391

object_name: insomnia


subject: CHEBI:64312

subject_name: Memantine

object_name: open-angle glaucoma


subject: CHEBI:180664

subject_name: Tempol

object_name: ototoxicity


subject: CHEBI:180664

object_name: mucositis


subject: CHEBI:180664

object_name: nephrotoxicity


subject: CHEBI:2611

subject_name: Alprazolam

object_name: AOD effects and consequences


subject: UMLS:C1971782

subject_name: DEXTROAMPHETAMINE SULFATE, 5 MG ADMINISTERED


subject: CHEBI:4469

subject_name: dexamfetamine


subject: UMLS:C2987407

object_name: cancer


subject: PUBCHEM.COMPOUND:22064497

subject_name: Elagolix

object_name: Menorrhagia


subject: CHEBI:23965

subject_name: estradiol


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate


subject: PUBCHEM.COMPOUND:541197


subject: CHEBI:7627

subject_name: Norethisterone


subject: PR:000015454

subject_name: sperm-associated antigen 11B


subject: PR:000015454


subject: PR:000022039

subject_name: dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex


subject: PR:000022039


subject: PR:000015453

subject_name: sperm-associated antigen 11A


subject: PR:000015453


subject: CHEBI:6931

subject_name: Midazolam

object_name: Complication of anesthesia


subject: CHEBI:91367

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:91367

object_name: acute myeloid leukemia


subject: UMLS:C1831923


subject: UMLS:C1831923


subject: CHEBI:135931

subject_name: Dexlansoprazole

object_name: Laryngopharyngeal Reflux


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Weight Gain


subject: CHEBI:85078

object_name: Weight Gain, CTCAE


subject: CHEBI:85078

object_name: HIV infection


subject: CHEBI:75722

subject_name: Tramadol

object_name: Shivering


subject: CHEBI:6121

subject_name: Ketamine


subject: UMLS:C0105747

subject_name: Bepanthen

object_name: Photodamaged skin


subject: CHEBI:27373

subject_name: Dexpanthenol


subject: UNII:WV9CM0O67Z

subject_name: Panthenol


subject: DRUGBANK:DB11058

subject_name: Petrolatum


subject: CHEBI:205919

subject_name: Clobetasol

object_name: vulvar lichen sclerosus


subject: PUBCHEM.COMPOUND:2723854

subject_name: Indigo carmine

object_name: colorectal neoplasm


subject: UNII:1G5BK41P4F

subject_name: Indigo


subject: CHEBI:90117

subject_name: indigo carmine


subject: UNII:3K6A6FJ98O

subject_name: Preimplantation factor

object_name: graft versus host disease


subject: CHEMBL.COMPOUND:CHEMBL4298118

subject_name: PREIMPLANTATION FACTOR


subject: UMLS:C3272414

subject_name: Preimplantation Factor PIF-1


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Hepatic impairment


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: high grade B-cell lymphoma


subject: UNII:3A189DH42V

object_name: diffuse large B-cell lymphoma


subject: UNII:3A189DH42V

object_name: non-Hodgkin lymphoma


subject: CHEBI:42944

subject_name: Galantamine

object_name: tardive dyskinesia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Prostate cancer recurrent


subject: CHEBI:4026

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:4026

object_name: prostate adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: skin basal cell carcinoma


subject: UMLS:C4053601


subject: CHEBI:45783

subject_name: Imatinib

object_name: adult oligodendroglioma


subject: CHEBI:45783

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:45783

object_name: Adult Mixed Glioma


subject: CHEBI:45783

object_name: Recurrent Adult Brain Neoplasm


subject: GTOPDB:5026

subject_name: NGF

object_name: Ischemic stroke


subject: UMLS:C3493499

object_name: kidney failure


subject: UMLS:C0032346

subject_name: Poisons

object_name: poisoning


subject: UMLS:C0032346

object_name: Drug toxicity


subject: UMLS:C0032346

object_name: poisoning with wrong medicinal drug


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: diabetic kidney disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: malnutrition


subject: UNII:14J2G0U3NQ

subject_name: Laromustine

object_name: Myelodysplasia


subject: UNII:14J2G0U3NQ

object_name: adult acute myeloid leukemia


subject: UNII:14J2G0U3NQ

object_name: childhood acute myeloid leukemia


subject: UNII:14J2G0U3NQ

object_name: acute myeloid leukemia


subject: UMLS:C1134489


subject: UMLS:C1134489


subject: UMLS:C1134489


subject: UMLS:C1134489


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Induced Abortion Finding


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: rhabdoid tumor


subject: CHEBI:231598

object_name: rhabdoid tumor of the kidney


subject: CHEBI:231598

object_name: epithelioid malignant peripheral nerve sheath tumor


subject: CHEBI:231598

object_name: Small cell carcinoma of the ovary, hypercalcemic type


subject: CHEBI:231598

object_name: desmoplastic small round cell tumor


subject: CHEBI:231598

object_name: poorly differentiated chordoma


subject: CHEBI:231598

object_name: kidney medullary carcinoma


subject: CHEBI:231598

object_name: collecting duct carcinoma


subject: CHEBI:231598

object_name: malignant myoepithelioma


subject: CHEBI:231598

object_name: malignant mesothelioma


subject: CHEBI:231598

object_name: spindle cell sarcoma


subject: CHEBI:231598

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:231598

object_name: clear cell renal carcinoma


subject: CHEBI:231598

object_name: renal cell adenocarcinoma


subject: CHEBI:231598

object_name: renal cell carcinoma


subject: CHEBI:231598

object_name: nasal cavity and paranasal sinus carcinoma


subject: CHEBI:231598

object_name: Childhood Synovial Sarcoma


subject: CHEBI:231598

object_name: Adult Synovial Sarcoma


subject: CHEBI:231598

object_name: synovial sarcoma


subject: CHEBI:231598

object_name: bone chondrosarcoma


subject: CHEBI:231598

object_name: chondrosarcoma


subject: CHEBI:231598

object_name: atypical teratoid rhabdoid tumor


subject: UMLS:C1134588

object_name: Neoplasm Metastasis


subject: CHEBI:63791


subject: MESH:C587280

subject_name: ojeok-san

object_name: familial cold autoinflammatory syndrome


subject: MESH:C587280

object_name: Cold Hypersensitivity


subject: MESH:C587280

object_name: familial cold autoinflammatory syndrome 1


subject: UMLS:C3852241

object_name: ulcerative colitis


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: endocarditis


subject: CHEBI:3534

subject_name: Cephalexin


subject: CHEBI:4511

subject_name: Dicloxacillin


subject: CHEBI:63607

subject_name: Linezolid


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: COPD exacerbation


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: PUBCHEM.COMPOUND:11422859

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: UMLS:C2825833

subject_name: Neugranin


subject: UMLS:C2825833

object_name: Chemotherapy induced neutropenia


subject: CHEBI:114785

subject_name: Erlotinib

object_name: acquired polycythemia vera


subject: CHEBI:71157

subject_name: Dobesilic acid

object_name: Menorrhagia


subject: CHEBI:71157

object_name: Menorrhagia, CTCAE


subject: CHEBI:71157

object_name: Abnormal uterine bleeding


subject: UMLS:C0877940

subject_name: Doxium


subject: UMLS:C0877940


subject: UMLS:C0877940


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Unexplained infertility


subject: UNII:PVI5M0M1GW

object_name: female; infertility, nonimplantation


subject: UNII:PVI5M0M1GW

object_name: female infertility of uterine origin


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:36121

subject_name: flavylium

object_name: Inflammation


subject: CHEBI:36121

object_name: Cognitive impairment


subject: CHEBI:36121

object_name: coronary artery disorder


subject: UMLS:C5401619

object_name: Transplant-Related Disorder


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: pelvic organ prolapse


subject: CHEBI:94534

subject_name: olanzapine

object_name: eating disorder


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: Peyronie disease


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: CHEBI:192614

subject_name: Homosildenafil


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UMLS:C1328652

subject_name: KOS 862

object_name: prostate carcinoma


subject: UMLS:C1328652

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:4622926

subject_name: Epothilone D


subject: PUBCHEM.COMPOUND:4622926


subject: CHEBI:75922

subject_name: Nepafenac


subject: CHEBI:75922

object_name: papilledema


subject: CHEBI:75922

object_name: retinal edema


subject: CHEBI:59175

object_name: cataract


subject: CHEBI:59175

object_name: Cataract, CTCAE 3.0


subject: CHEBI:59175

object_name: Cataract, CTCAE 5.0


subject: CHEBI:59175

object_name: cataract on exam (physical finding)


subject: CHEBI:59175


subject: CHEBI:59175


subject: CHEBI:59175


subject: CHEBI:240107

subject_name: Bromfenac


subject: CHEBI:240107


subject: CHEBI:26195

subject_name: polyphenol

object_name: hemochromatosis


subject: CHEBI:26195

object_name: Iron absorption level


subject: CHEBI:6456

subject_name: Lidocaine

object_name: syphilis infection


subject: CHEBI:6456

object_name: Benzathine penicillin adverse reaction


subject: CHEBI:94688

subject_name: Acipimox

object_name: type 2 diabetes mellitus


subject: CHEBI:94688

object_name: Diabetes


subject: CHEBI:94688

object_name: diabetes mellitus


subject: CHEBI:94688

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:94688

object_name: obesity


subject: CHEBI:94688

object_name: Obesity, CTCAE


subject: CHEBI:50730

subject_name: Montelukast

object_name: sickle cell disease


subject: CHEBI:50730

object_name: sleep apnea


subject: UMLS:C4745049

subject_name: PRMT1 Inhibitor GSK3368715

object_name: neoplasm


subject: UMLS:C4733241

object_name: Childhood Breast Carcinoma


subject: UMLS:C4733241

object_name: breast carcinoma


subject: UMLS:C4733241

object_name: breast cancer


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: ulcerative colitis


subject: CHEBI:22652

object_name: inflammatory bowel disease 1


subject: UNII:95D580798S

subject_name: Picosulfuric acid


subject: UNII:95D580798S


subject: CHEBI:41423

subject_name: Celecoxib

object_name: gout


subject: UMLS:C3489692

subject_name: CAPIRI

object_name: biliary tract cancer


subject: UMLS:C3489692

object_name: liver carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:28X28X9OKV

object_name: childhood malignant neoplasm


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3854325

subject_name: Janus kinase inhibitor

object_name: rheumatoid arthritis


subject: UMLS:C5978811

subject_name: Vitamin C Gummy

object_name: Dietary Exposure


subject: CHEBI:48775

object_name: mucositis


subject: GTOPDB:2440


subject: UMLS:C2347546


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Adult Solid Neoplasm


subject: UMLS:C5432278


subject: CHEBI:52717

subject_name: Bortezomib

object_name: melanoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: Collagen degeneration


subject: PUBCHEM.COMPOUND:133604

object_name: sarcopenia


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: UMLS:C0543134

subject_name: Balanced salt solution

object_name: glaucoma


subject: UMLS:C0543134

object_name: Glaucoma, CTCAE


subject: PUBCHEM.COMPOUND:66621102

object_name: HIV infection


subject: CHEBI:85089

subject_name: Ledipasvir


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Thoracic Diseases


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: nephrotic syndrome


subject: CHEBI:28887

object_name: Nephrotic Syndrome, CTCAE


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: arthritis


subject: UNII:7D0YB67S97

object_name: Arthritis, CTCAE


subject: UNII:7D0YB67S97

object_name: Arthralgia


subject: UNII:7D0YB67S97

object_name: Arthralgia, CTCAE


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C3896909

object_name: adult acute myeloid leukemia


subject: UMLS:C3896909

object_name: childhood acute myeloid leukemia


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879

object_name: acute myeloid leukemia


subject: CHEBI:229762

subject_name: Eltanexor


subject: CHEBI:229762


subject: CHEBI:229762


subject: UMLS:C4086976


subject: UMLS:C4086976


subject: UMLS:C4086976


subject: CHEBI:95165

object_name: Solid Neoplasm


subject: CHEBI:95165

object_name: B-cell neoplasm


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: PUBCHEM.COMPOUND:49857317

subject_name: Nanatinostat

object_name: nasopharyngeal carcinoma


subject: PUBCHEM.COMPOUND:49857317

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: PUBCHEM.COMPOUND:49857317

object_name: Epstein-Barr virus-associated carcinoma


subject: PUBCHEM.COMPOUND:49857317

object_name: Epstein-Barr virus-associated gastric carcinoma


subject: PUBCHEM.COMPOUND:49857317

object_name: EBV-Related Leiomyosarcoma


subject: PUBCHEM.COMPOUND:49857317

object_name: EBV-Related Sarcoma


subject: UNII:YTL7A418KQ


subject: UNII:YTL7A418KQ


subject: UNII:YTL7A418KQ


subject: UNII:YTL7A418KQ


subject: UNII:YTL7A418KQ


subject: UNII:YTL7A418KQ


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:63635

subject_name: Valganciclovir


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:63635